IGC Pharma
IGC
#10699
Rank
A$36.81 M
Marketcap
A$0.36
Share price
1.59%
Change (1 day)
-44.58%
Change (1 year)
IGC Pharma, Inc. (formerly India Globalization Capital, Inc.) is a clinical-stage pharmaceutical company focused on developing advanced treatments for diseases, with a primary focus on Alzheimer's disease and other neurological conditions.

IGC Pharma (IGC) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : A$4.36 Million

According to IGC Pharma's latest financial reports the company's total liabilities are A$4.36 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

IGC Pharma - Total liabilities on balance sheet (from 2006 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-03-31A$3.87 M-1.99%
2024-03-31A$3.95 M16.71%
2023-03-31A$3.38 M-13.8%
2022-03-31A$3.92 M-2.67%
2021-03-31A$4.03 M1.19%
2020-03-31A$3.98 M217.64%
2019-03-31A$1.25 M-65.41%
2018-03-31A$3.62 M-29.47%
2017-03-31A$5.14 M-19.65%
2016-03-31A$6.4 M-12.66%
2015-03-31A$7.33 M89.32%
2014-03-31A$3.87 M-5.76%
2013-03-31A$4.1 M-54.84%
2012-03-31A$9.09 M-13.5%
2011-03-31A$10.51 M5.07%
2010-03-31A$10.01 M-49.93%
2009-03-31A$19.99 M-31.18%
2008-03-31A$29.04 M32.13%
2007-03-31A$21.98 M-1.53%
2006-03-31A$22.32 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Sterling Infrastructure
STRL
A$2.56 B 58,767.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Trinity Industries
TRN
A$10.09 B 231,176.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Granite Construction
GVA
A$5.66 B 129,584.73%๐Ÿ‡บ๐Ÿ‡ธ USA